Mumtaz, Khalid
The Ohio State University
2 papers on CoChatORCID 0000-0001-7868-6514
Most cited papers
- Verified
Impacts of glucagon‐like peptide‐1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction‐associated steatotic liver disease cirrhosis and type 2 diabetes
Elsaid, M. I., Li, N., Firkins, S. A., Rustgi, V. K., Paskett, E. D., Acharya, C., Reddy, K. R., Chiang, C. W., & Mumtaz, K. (2024) · Alimentary Pharmacology & Therapeutics
Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management
Cited by 77
- Verified
Bariatric Surgery in Patients with Cirrhosis: Careful Patient and Surgery-Type Selection Is Key to Improving Outcomes
Mumtaz, K., Lipshultz, H., Jalil, S., Porter, K., Li, N., Kelly, S. G., Conteh, L. F., Michaels, A., Hanje, J., Black, S., et al. (2020) · Obesity Surgery
Bariatric Surgery and OutcomesLiver Disease and Transplantation
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free